TY - JOUR
T1 - Soluble CD14 and Risk of Heart Failure and Its Subtypes in Older Adults
AU - Al-Kindi, Sadeer G.
AU - Buzkova, Petra
AU - Shitole, Sanyog G.
AU - Reiner, Alex P.
AU - Garg, Parveen K.
AU - Gottdiener, John S.
AU - Psaty, Bruce M.
AU - Kizer, Jorge R.
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/5
Y1 - 2020/5
N2 - Background: CD14 is a membrane glycoprotein primarily expressed by myeloid cells that plays a key role in inflammation. Soluble CD14 (sCD14) levels carry a poor prognosis in chronic heart failure (HF), but whether elevations in sCD14 precede HF is unknown. We tested the hypothesis that sCD14 is associated with HF incidence and its subtypes independent of major inflammatory biomarkers among older adults. Methods and Results: We included participants in the Cardiovascular Health Study without preexisting HF and available baseline sCD14. We evaluated the associations of sCD14, high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, and white blood cell count (WBC) with incident HF and subtypes using Cox regression. Among 5217 participants, 1878 had incident HF over 13.6 years (609 classifiable as HF with preserved ejection fraction [HFpEF] and 419 as HF with reduced ejection fraction [HFrEF]). After adjusting for clinical and laboratory covariates, sCD14 was significantly associated with incident HF (hazard ratio [HR]: 1.56 per doubling, 95% confidence interval [CI]: 1.29–1.89), an association that was numerically stronger than for hsCRP (HR per doubling: 1.10, 95% CI: 1.06–1.15), IL-6 (HR: 1.18, 95% CI: 1.10–1.25), and WBC (HR: 1.24, 95% CI: 1.09–1.42), and that remained significant after adjustment for the other markers of inflammation. This association for sCD14 was observed with HFpEF (HR: 1.50, 95% CI: 1.07–2.10) but not HFrEF (HR: 0.99, 95% CI: 0.67–1.49). Conclusions: Plasma sCD14 was associated with incident HF independently and numerically more strongly than other major inflammatory markers. This association was only observed with HFpEF in the subset with classifiable HF subtypes. Pending replication, these findings have potentially important therapeutic implications.
AB - Background: CD14 is a membrane glycoprotein primarily expressed by myeloid cells that plays a key role in inflammation. Soluble CD14 (sCD14) levels carry a poor prognosis in chronic heart failure (HF), but whether elevations in sCD14 precede HF is unknown. We tested the hypothesis that sCD14 is associated with HF incidence and its subtypes independent of major inflammatory biomarkers among older adults. Methods and Results: We included participants in the Cardiovascular Health Study without preexisting HF and available baseline sCD14. We evaluated the associations of sCD14, high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, and white blood cell count (WBC) with incident HF and subtypes using Cox regression. Among 5217 participants, 1878 had incident HF over 13.6 years (609 classifiable as HF with preserved ejection fraction [HFpEF] and 419 as HF with reduced ejection fraction [HFrEF]). After adjusting for clinical and laboratory covariates, sCD14 was significantly associated with incident HF (hazard ratio [HR]: 1.56 per doubling, 95% confidence interval [CI]: 1.29–1.89), an association that was numerically stronger than for hsCRP (HR per doubling: 1.10, 95% CI: 1.06–1.15), IL-6 (HR: 1.18, 95% CI: 1.10–1.25), and WBC (HR: 1.24, 95% CI: 1.09–1.42), and that remained significant after adjustment for the other markers of inflammation. This association for sCD14 was observed with HFpEF (HR: 1.50, 95% CI: 1.07–2.10) but not HFrEF (HR: 0.99, 95% CI: 0.67–1.49). Conclusions: Plasma sCD14 was associated with incident HF independently and numerically more strongly than other major inflammatory markers. This association was only observed with HFpEF in the subset with classifiable HF subtypes. Pending replication, these findings have potentially important therapeutic implications.
KW - CD14
KW - heart failure
KW - inlfammation
UR - http://www.scopus.com/inward/record.url?scp=85083502833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083502833&partnerID=8YFLogxK
U2 - 10.1016/j.cardfail.2020.03.003
DO - 10.1016/j.cardfail.2020.03.003
M3 - Article
C2 - 32165348
AN - SCOPUS:85083502833
SN - 1071-9164
VL - 26
SP - 410
EP - 419
JO - Journal of Cardiac Failure
JF - Journal of Cardiac Failure
IS - 5
ER -